Comment on CMS-2026-1255-0001

American Psychiatric AssociationSupportAdvocacy
Summary: The American Psychiatric Association (APA) supports the proposed rule to expand electronic prior authorization requirements and shorten decision timeframes for prescription drugs. While supporting the move toward interoperability, the APA urges CMS to provide technical assistance and financial support to psychiatric practices, and recommends a phased approach to transitioning to structured data formats.
See attached file

View on Regulations.gov